Artelo Biosciences, Inc. financial statements (2020 and earlier)

Company profile

Business Address 888 PROSPECT STREET, SUITE 210
LA JOLLA, CA 92037
State of Incorp. NV
Fiscal Year End August 31
SIC 7389 - Business Services, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2019
TTM
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,3754,424337573417
Cash and cash equivalents3,3754,424337573417
Receivables46922   
Prepaid expense86     
Deposits current assets22    
Other undisclosed current assets 8372  
Total current assets:3,5084,443396574417
Noncurrent Assets
Property, plant and equipment111   
Intangible assets, net (including goodwill)2,0392,039    
Intangible assets, net (excluding goodwill)2,0392,039    
Total noncurrent assets:2,0402,0401   
TOTAL ASSETS:5,5486,483397574417
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 34952929132
Other undisclosed accounts payable and accrued liabilities 34952929132
Derivative instruments and hedges, liabilities 30    
Due to related parties104314 
Other undisclosed current liabilities575639    
Total current liabilities:5851,02253229172
Noncurrent Liabilities
Total liabilities:5851,02253229172
Stockholders' equity
Stockholders' equity attributable to parent4,9635,461(135)545(14)15
Common stock33141188
Common stock, share subscribed but unissued, subscriptions receivable     (1)
Additional paid in capital11,07110,2782,5028283939
Accumulated other comprehensive income (loss)7(10)(12)1  
Accumulated deficit(6,117)(4,811)(2,639)(295)(60)(31)
Total stockholders' equity:4,9635,461(135)545(14)15
TOTAL LIABILITIES AND EQUITY:5,5486,483397574417

Income statement (P&L) ($ in thousands)

11/30/2019
TTM
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
Operating expenses(4,185)(3,210)(2,343)(233)(30)(15)
Operating loss:(4,185)(3,210)(2,343)(233)(30)(15)
Nonoperating income (expense)8421,037 (2)  
Other nonoperating income62631    
Interest and debt expense   (2)  
Net loss:(3,342)(2,172)(2,343)(237)(30)(15)
Other undisclosed net income attributable to parent   2  
Net loss available to common stockholders, diluted:(3,342)(2,172)(2,343)(235)(30)(15)

Comprehensive Income ($ in thousands)

11/30/2019
TTM
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
Net loss:(3,342)(2,172)(2,343)(237)(30)(15)
Comprehensive loss:(3,342)(2,172)(2,343)(237)(30)(15)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent182(13)3  
Comprehensive loss, net of tax, attributable to parent:(3,324)(2,170)(2,356)(234)(30)(15)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: